Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
NCT03856047 prespecified antibody occurrence against cagrilintide as a secondary endpoint, and excluded antibody follow-up time from the in-trial period [6]
Strinic D, Belosic Halle Z, Luetic K, Nedic A, Petrovic I, Sucic M, Zivanovic Posilovic G, Balenovic D, Strbe S, Udovicic M, Drmic D, Stupnisek M, Lovric Bencic M, Seiwerth S, Sikiric P
Investment return and principal value of security investments will fluctuate
The full TRIUMPH program enrolled more than 5,800 participants across multiple Phase 3 trials
Stimulation of gonadotropin-releasing hormone secretion by acetyl-L-carnitine in hypothalamic neurons and GT1 neuronal cells Neurosci Lett 1994
US$ 29.62
US$ 29.68
US$ 26.66
